Currently 38 million Americans have some degree of hearing loss, in many cases caused by exposure to excessive levels of noise. Although hearing protection devices are available to help prevent noise-induced hearing loss, they are not always effective, and in some situations, they can be impractical to use. In addition, hearing loss can be caused by aging and ototoxic drugs, such as the cancer drug cisplatin. A serious disorder associated with hearing loss is tinnitus (ringing in the ears). Currently, there are no effective medications or nutraceuticals to prevent and treat these common and sometimes debilitating hearing disorders.
Founded in 2011, Gateway Biotechnology, Inc., is focused on identifying agents to prevent and treat hearing disorders. Our unique approaches are:
Our determination to improve the quality of life for people with hearing disorders has led to the funding of 4 STTR and SBIR (Small Business Innovation Research and Small Business Technology Transfer) awards from the NIH (National Institutes of Health), and one approval of a clinical trial by FDA (U.S. Food and Drug Administration). These successes have enabled us to develop 3 nutraceutical products and 4 drug-repurposing product lines for the treatment of hearing disorders.